Clinical Trials Browser

Phase 1 × Small Cell Lung Carcinoma × Imatinib Mesylate × Clear all

NCT00052494 2015-07-23

Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1 Completed

Lung Neoplasms, Small Cell Lung Carcinoma